{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:07:18Z","timestamp":1790946438717,"version":"4.1.0"},"reference-count":125,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","award":["STR1095\/6-1"],"award-info":[{"award-number":["STR1095\/6-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011022","name":"Vertex Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014931","name":"Arrowhead Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014931","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009253","name":"EASL International Liver Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009253","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jhep.2021.11.022","type":"journal-article","created":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T10:56:33Z","timestamp":1638010593000},"page":"946-958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Alpha-1 antitrypsin deficiency: A re-surfacing adult liver disorder"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0382-5705","authenticated-orcid":false,"given":"Malin","family":"Fromme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6728-9246","authenticated-orcid":false,"given":"Carolin V.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6895-8819","authenticated-orcid":false,"given":"Nicola","family":"Brunetti-Pierri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7122-6379","authenticated-orcid":false,"given":"Pavel","family":"Strnad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2021.11.022_bib1","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMra1910234","article-title":"Alpha1-Antitrypsin deficiency","volume":"382","author":"Strnad","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2021.11.022_bib2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3389\/fphar.2018.00341","article-title":"The multifaceted effects of alpha1-antitrypsin on neutrophil functions","volume":"9","author":"Janciauskiene","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jhep.2021.11.022_bib3","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.rmed.2011.02.002","article-title":"The discovery of alpha1-antitrypsin and its role in health and disease","volume":"105","author":"Janciauskiene","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.jhep.2021.11.022_bib4","doi-asserted-by":"crossref","first-page":"16051","DOI":"10.1038\/nrdp.2016.51","article-title":"alpha1-Antitrypsin deficiency","volume":"2","author":"Greene","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jhep.2021.11.022_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00198-2017","article-title":"Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits","volume":"50","author":"Tanash","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jhep.2021.11.022_bib6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/archpedi.160.5.531","article-title":"Genetic testing of minors for alpha1-antitrypsin deficiency","volume":"160","author":"Strange","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jhep.2021.11.022_bib7","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/j.2040-4603.2013.tb00527.x","article-title":"Broad spectrum of hepatocyte inclusions in humans, animals, and experimental models","volume":"3","author":"Strnad","year":"2013","journal-title":"Compr Physiol"},{"key":"10.1016\/j.jhep.2021.11.022_bib8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13023-014-0172-y","article-title":"Identification and characterisation of eight novel SERPINA1 Null mutations","volume":"9","author":"Ferrarotti","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jhep.2021.11.022_bib9","first-page":"96","article-title":"The Pi system-inherited variants of serum alpha 1-antitrypsin","volume":"7","author":"Fagerhol","year":"1970","journal-title":"Prog Med Genet"},{"issue":"Suppl C","key":"10.1016\/j.jhep.2021.11.022_bib10","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1053\/rmed.2000.0851","article-title":"Molecular mechanisms of alpha1-antitrypsin null alleles","volume":"94","author":"Lee","year":"2000","journal-title":"Respir Med"},{"key":"10.1016\/j.jhep.2021.11.022_bib11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1126\/science.181.4094.70","article-title":"1 -Antitrypsin deficiency: a variant with no detectable\u00a01 -antitrypsin","volume":"181","author":"Talamo","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.jhep.2021.11.022_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-2466-14-132","article-title":"The significance of the F variant of alpha-1-antitrypsin and unique case report of a PiFF homozygote","volume":"14","author":"Sinden","year":"2014","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jhep.2021.11.022_bib13","series-title":"\u03b11-Antitrypsin deficiency ERS monograph no 85 Lausanne, Swit- zerland","article-title":"Serinopathies","author":"Lomas","year":"2019"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2021.11.022_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/15412555.2013.765839","article-title":"Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy","volume":"10","author":"Teckman","year":"2013","journal-title":"Copd"},{"key":"10.1016\/j.jhep.2021.11.022_bib15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2019.05.013","article-title":"Liver fibrosis and metabolic alterations in adults with alpha-1-antitrypsin deficiency caused by the Pi\u2217ZZ mutation","volume":"157","author":"Hamesch","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.11.022_bib16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2147\/COPD.S125389","article-title":"Alpha-1 antitrypsin Pi\u2217Z gene frequency and Pi\u2217ZZ genotype numbers worldwide: an update","volume":"12","author":"Blanco","year":"2017","journal-title":"Int J chronic obstructive Pulm Dis"},{"key":"10.1016\/j.jhep.2021.11.022_bib17","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2147\/COPD.S137852","article-title":"Alpha-1 antitrypsin Pi\u2217SZ genotype: estimated prevalence and number of SZ subjects worldwide","volume":"12","author":"Blanco","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jhep.2021.11.022_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/gutjnl-2020-323729","article-title":"Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency","volume":"71","author":"Fromme","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.11.022_bib19","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/357605a0","article-title":"The mechanism of Z alpha 1-antitrypsin accumulation in the liver","volume":"357","author":"Lomas","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2021.11.022_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-7163-3_1","article-title":"Pathophysiology of alpha-1 antitrypsin deficiency liver disease","volume":"1639","author":"Teckman","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jhep.2021.11.022_bib21","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ncb1689","article-title":"OS-9 and GRP94 deliver mutant alpha1-antitrypsin to the Hrd1-SEL1L ubiquitin ligase complex for ERAD","volume":"10","author":"Christianson","year":"2008","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jhep.2021.11.022_bib22","doi-asserted-by":"crossref","first-page":"G961","DOI":"10.1152\/ajpgi.2000.279.5.G961","article-title":"Retention of mutant alpha(1)-antitrypsin Z in endoplasmic reticulum is associated with an autophagic response","volume":"279","author":"Teckman","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jhep.2021.11.022_bib23","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1073\/pnas.1713689115","article-title":"Editing out five Serpina1 paralogs to create a mouse model of genetic emphysema","volume":"115","author":"Borel","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2021.11.022_bib24","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.4161\/auto.24469","article-title":"Autophagy master regulator TFEB induces clearance of toxic SERPINA1\/\u03b1-1-antitrypsin polymers","volume":"9","author":"Pastore","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.jhep.2021.11.022_bib25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1126\/science.1190354","article-title":"An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis","volume":"329","author":"Hidvegi","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jhep.2021.11.022_bib26","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1258\/ebm.2010.009297","article-title":"Rapamycin reduces intrahepatic alpha-1-antitrypsin mutant Z protein polymers and liver injury in a mouse model","volume":"235","author":"Kaushal","year":"2010","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.jhep.2021.11.022_bib27","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.4049\/jimmunol.172.9.5722","article-title":"Activation of endoplasmic reticulum-specific stress responses associated with the conformational disease Z alpha 1-antitrypsin deficiency","volume":"172","author":"Lawless","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jhep.2021.11.022_bib28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41418-018-0130-7","article-title":"NF\u03baB mitigates the pathological effects of misfolded \u03b11-antitrypsin by activating autophagy and an integrated program of proteostasis mechanisms","volume":"26","author":"Mukherjee","year":"2019","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jhep.2021.11.022_bib29","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1002\/hep.29035","article-title":"Activation of the c-Jun N-terminal kinase pathway aggravates proteotoxicity of hepatic mutant Z alpha1-antitrypsin","volume":"65","author":"Pastore","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.11.022_bib30","doi-asserted-by":"crossref","first-page":"13213","DOI":"10.1074\/jbc.RA120.014307","article-title":"CHOP and c-JUN up-regulate the mutant Z \u03b1(1)-antitrypsin, exacerbating its aggregation and liver proteotoxicity","volume":"295","author":"Attanasio","year":"2020","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhep.2021.11.022_bib31","first-page":"118","article-title":"Up-regulation of miR-34b\/c by JNK and FOXO3 protects from liver fibrosis","author":"Piccolo","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2021.11.022_bib32","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1172\/JCI0216787","article-title":"Liver injury in alpha1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury","volume":"110","author":"Perlmutter","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2021.11.022_bib33","first-page":"80","article-title":"Dual proteotoxic stress accelerates liver injury via activation of p62-Nrf2","volume":"254","author":"Kuscuoglu","year":"2021","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.jhep.2021.11.022_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111415","article-title":"Mild iron overload as seen in individuals homozygous for the alpha-1 antitrypsin Pi\u2217Z variant does not promote liver fibrogenesis in HFE knockout mice","volume":"8","author":"Guldiken","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jhep.2021.11.022_bib35","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/hep.21326","article-title":"Indomethacin increases liver damage in a murine model of liver injury from alpha-1-antitrypsin deficiency","volume":"44","author":"Rudnick","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.11.022_bib36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1172\/JCI67968","article-title":"Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin-related liver disease in mice","volume":"124","author":"Guo","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2021.11.022_bib37","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature10424","article-title":"Targeted gene correction of \u03b11-antitrypsin deficiency in induced pluripotent stem cells","volume":"478","author":"Yusa","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2021.11.022_bib38","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nprot.2012.153","article-title":"Production of hepatocyte-like cells from human pluripotent stem cells","volume":"8","author":"Hannan","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jhep.2021.11.022_bib39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/hep.27753","article-title":"Induced pluripotent stem cells model personalized variations in liver disease resulting from \u03b11-antitrypsin deficiency","volume":"62","author":"Tafaleng","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.11.022_bib40","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jhep.2018.05.028","article-title":"hiPSC hepatocyte model demonstrates the role of unfolded protein response and inflammatory networks in \u03b1(1)-antitrypsin deficiency","volume":"69","author":"Segeritz","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.11.022_bib41","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","article-title":"Long-term culture of genome-stable bipotent stem cells from adult human liver","volume":"160","author":"Huch","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2021.11.022_bib42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12072-019-10007-y","article-title":"Liver organoids reproduce alpha-1 antitrypsin deficiency-related liver disease","volume":"14","author":"G\u00f3mez-Mariano","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2021.11.022_bib43","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/hep.29160","article-title":"Down-regulation of hepatocyte nuclear factor-4\u03b1 and defective zonation in livers expressing mutant Z \u03b11-antitrypsin","volume":"66","author":"Piccolo","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.11.022_bib44","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201899259","article-title":"ER-to-lysosome-associated degradation of proteasome-resistant ATZ polymers occurs via receptor-mediated vesicular transport","volume":"37","author":"Fregno","year":"2018","journal-title":"Embo J"},{"key":"10.1016\/j.jhep.2021.11.022_bib45","doi-asserted-by":"crossref","first-page":"8229","DOI":"10.1073\/pnas.1430537100","article-title":"Elucidation of the molecular logic by which misfolded alpha 1-antitrypsin is preferentially selected for degradation","volume":"100","author":"Wu","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2021.11.022_bib46","doi-asserted-by":"crossref","first-page":"24825","DOI":"10.1073\/pnas.1919013117","article-title":"The cytoplasmic tail of human mannosidase Man1b1 contributes to catalysis-independent quality control of misfolded alpha1-antitrypsin","volume":"117","author":"Sun","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jhep.2021.11.022_bib47","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nsmb.2111","article-title":"Derlin-1 is a rhomboid pseudoprotease required for the dislocation of mutant \u03b1-1 antitrypsin from the endoplasmic reticulum","volume":"18","author":"Greenblatt","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.jhep.2021.11.022_bib48","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12964-020-00648-0","article-title":"Alpha-1 antitrypsin deficient individuals have circulating extracellular vesicles with profibrogenic cargo","volume":"18","author":"Khodayari","year":"2020","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.jhep.2021.11.022_bib49","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/liv.14035","article-title":"Liver disease related to alpha1-antitrypsin deficiency in French children: the DEFI-ALPHA cohort","volume":"39","author":"Ruiz","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.11.022_bib50","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJM197606102942404","article-title":"Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants","volume":"294","author":"Sveger","year":"1976","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2021.11.022_bib51","first-page":"514","article-title":"The liver in adolescents with alpha 1-antitrypsin deficiency","volume":"22","author":"Sveger","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.11.022_bib52","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2147\/COPD.S183205","article-title":"Survival in the Swedish cohort with alpha-1-antitrypsin deficiency, up to the age of 43-45 years","volume":"14","author":"Mostafavi","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jhep.2021.11.022_bib53","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/liv.14064","article-title":"DEFI-ALFA: the French key to the alpha1 mystery?","volume":"39","author":"Fromme","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2021.11.022_bib54","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/gutjnl-2018-316228","article-title":"Heterozygous carriage of the alpha1-antitrypsin Pi\u2217Z variant increases the risk to develop liver cirrhosis","volume":"68","author":"Strnad","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.11.022_bib55","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1053\/j.gastro.2020.04.058","article-title":"Liver phenotypes of European adults heterozygous or homozygous for Pi\u2217Z variant of AAT (Pi\u2217MZ vs Pi\u2217ZZ genotype) and non-carriers","volume":"159","author":"Schneider","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.11.022_bib56","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jhep.2018.08.005","article-title":"Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort","volume":"69","author":"Clark","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.11.022_bib57","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)","volume":"57","author":"Adam","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.11.022_bib58","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1053\/j.gastro.2021.01.002","article-title":"Response to: the Pi\u2217MZ allele in alpha-1 antitrypsin increases liver-related outcomes in a population-based study","volume":"160","author":"Schneider","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.11.022_bib59","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMra1610570","article-title":"Use of liver imaging and biopsy in clinical practice","volume":"377","author":"Tapper","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2021.11.022_bib60","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-1-4939-7163-3_13","article-title":"Immunohistochemistry staining for human alpha-1 antitrypsin","volume":"1639","author":"Fu","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jhep.2021.11.022_bib61","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jhep.2019.08.011","article-title":"Assessment of liver phenotype in adults with severe alpha-1 antitrypsin deficiency (Pi\u2217ZZ genotype)","volume":"71","author":"Kumpers","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.11.022_bib62","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/apt.13691","article-title":"Magnetic resonance elastography identifies fibrosis in adults with alpha-1 antitrypsin deficiency liver disease: a prospective study","volume":"44","author":"Kim","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2021.11.022_bib63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/15412555.2015.1021912","article-title":"Spanish registry of patients with alpha-1 antitrypsin deficiency; comparison of the characteristics of PISZ and PIZZ individuals","volume":"12","author":"Lara","year":"2015","journal-title":"Copd"},{"key":"10.1016\/j.jhep.2021.11.022_bib64","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1001\/jama.2009.1295","article-title":"Genetic modifiers of liver disease in cystic fibrosis","volume":"302","author":"Bartlett","year":"2009","journal-title":"Jama"},{"key":"10.1016\/j.jhep.2021.11.022_bib65","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa1712191","article-title":"A\u00a0protein-truncating HSD17B13 variant and protection from chronic liver disease","volume":"378","author":"Abul-Husn","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2021.11.022_bib66","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/ng.3855","article-title":"Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci","volume":"49","author":"Stender","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2021.11.022_bib67","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0140-6736(14)61838-9","article-title":"Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis","volume":"384","author":"Williams","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2021.11.022_bib68","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jhep.2021.11.022_bib69","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","article-title":"Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease","volume":"69","author":"Lebeaupin","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.11.022_bib70","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/s41556-018-0235-8","article-title":"Autophagy and the cell biology of age-related disease","volume":"20","author":"Leidal","year":"2018","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.jhep.2021.11.022_bib71","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0140-6736(15)60860-1","article-title":"Intravenous augmentation treatment and lung density in severe \u03b11 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial","volume":"386","author":"Chapman","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2021.11.022_bib72","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-2600(16)30430-1","article-title":"Long-term efficacy and safety of \u03b11 proteinase inhibitor treatment for emphysema caused by severe \u03b11 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)","volume":"5","author":"McElvaney","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jhep.2021.11.022_bib73","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.dld.2020.10.016","article-title":"Long term results of liver transplantation for alpha-1 antitrypsin deficiency","volume":"53","author":"Guillaud","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhep.2021.11.022_bib74","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/lt.23744","article-title":"Outcomes for recipients of liver transplantation for alpha-1-antitrypsin deficiency-related cirrhosis","volume":"19","author":"Carey","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2021.11.022_bib75","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/apt.14537","article-title":"Systematic review: the natural history of alpha-1 antitrypsin deficiency, and associated liver disease","volume":"47","author":"Townsend","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2021.11.022_bib76","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/lt.25057","article-title":"Heterozygosity for the alpha-1-antitrypsin Z allele in cirrhosis is associated with more advanced disease","volume":"24","author":"Schaefer","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2021.11.022_bib77","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jhep.2018.03.012","article-title":"Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients","volume":"69","author":"Turner","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2021.11.022_bib78","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1073\/pnas.97.4.1796","article-title":"Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: a potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency","volume":"97","author":"Burrows","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2021.11.022_bib79","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1074\/jbc.C100722200","article-title":"6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin-related cirrhosis","volume":"277","author":"Mahadeva","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jhep.2021.11.022_bib80","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1165\/rcmb.2005-0207OC","article-title":"Identification of a 4-mer peptide inhibitor that effectively blocks the polymerization of pathogenic Z alpha1-antitrypsin","volume":"35","author":"Chang","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jhep.2021.11.022_bib81","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1096\/fj.14-267351","article-title":"A\u00a0single-chain variable fragment intrabody prevents intracellular polymerization of Z \u03b11-antitrypsin while allowing its antiproteinase activity","volume":"29","author":"Ord\u00f3\u00f1ez","year":"2015","journal-title":"Faseb J"},{"key":"10.1016\/j.jhep.2021.11.022_bib82","doi-asserted-by":"crossref","first-page":"e13167","DOI":"10.15252\/emmm.202013167","article-title":"Development of a small molecule that corrects misfolding and increases secretion of Z \u03b1(1) -antitrypsin","volume":"13","author":"Lomas","year":"2021","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jhep.2021.11.022_bib83","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc1370","article-title":"The structural basis for Z \u03b1(1)-antitrypsin polymerization in the liver","volume":"6","author":"Faull","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.jhep.2021.11.022_bib84","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.coph.2021.06.001","article-title":"Alpha1-antitrypsin deficiency: new therapies on the horizon","volume":"59","author":"Remih","year":"2021","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jhep.2021.11.022_bib85","article-title":"ARO-AAT reduces serum and intra-hepatic Z-AAT protein in PiZZ alpha-1 antitrypsin deficient patients with liver disease leading to improvements in clinically relevant liver biomarkers","author":"Strnad","year":"2020","journal-title":"AASLD The Liver Meet Digital Experience"},{"key":"10.1016\/j.jhep.2021.11.022_bib86","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/cdd.2008.103","article-title":"Autophagic disposal of the aggregation-prone protein that causes liver inflammation and carcinogenesis in alpha-1-antitrypsin deficiency","volume":"16","author":"Perlmutter","year":"2009","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jhep.2021.11.022_bib87","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jmb.2004.07.078","article-title":"How small peptides block and reverse serpin polymerisation","volume":"342","author":"Zhou","year":"2004","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.jhep.2021.11.022_bib88","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/embor.2011.171","article-title":"Molecular basis of \u03b11-antitrypsin deficiency revealed by the structure of a domain-swapped trimer","volume":"12","author":"Yamasaki","year":"2011","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jhep.2021.11.022_bib89","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12694","article-title":"Anti-inflammaging effects of human alpha-1 antitrypsin","volume":"17","author":"Yuan","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.jhep.2021.11.022_bib90","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/hep.27024","article-title":"\u03b1-1-antitrypsin inhibits acute liver failure in mice","volume":"59","author":"Jedicke","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.11.022_bib91","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/gutjnl-2020-321375","article-title":"Alpha-1 antitrypsin governs alcohol-related liver disease in mice and humans","volume":"70","author":"Grander","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.11.022_bib92","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41467-021-21972-0","article-title":"Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection","volume":"12","author":"Wettstein","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2021.11.022_bib93","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1164\/rccm.202104-0833LE","article-title":"Therapeutic application of alpha-1 antitrypsin in COVID-19","volume":"204","author":"Ritzmann","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jhep.2021.11.022_bib94","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/rccm.168.7.818","article-title":"American Thoracic Society\/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency","volume":"168","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jhep.2021.11.022_bib95","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1053\/j.gastro.2020.10.061","article-title":"The Pi\u2217MZ allele in alpha-1 antitrypsin increases liver-related outcomes in a population-based study","volume":"160","author":"Luukkonen","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2021.11.022_bib96","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep4.1718","article-title":"Heterozygosity of the alpha 1-antitrypsin Pi\u2217Z allele and risk of liver disease","volume":"5","author":"Hakim","year":"2021","journal-title":"Hepatol Commun"},{"issue":"Suppl 1","key":"10.1016\/j.jhep.2021.11.022_bib97","first-page":"S30","article-title":"Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver diseases? Interim results of a large case-control study","volume":"43","author":"Regev","year":"2006","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2021.11.022_bib98","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/MEG.0000000000000061","article-title":"Pi\u2217Z heterozygous alpha-1 antitrypsin states accelerate parenchymal but not biliary cirrhosis","volume":"26","author":"Cacciottolo","year":"2014","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2021.11.022_bib99","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00428-014-1633-3","article-title":"Alpha(1)-antitrypsin PiMZ heterozygosity has an independent aggravating effect on liver fibrosis in alcoholic liver disease","volume":"465","author":"Goltz","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jhep.2021.11.022_bib100","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-117-8-641","article-title":"High prevalence of viral infection in adults with homozygous and heterozygous alpha 1-antitrypsin deficiency and chronic liver disease","volume":"117","author":"Propst","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2021.11.022_bib101","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.hepres.2005.09.035","article-title":"High prevalence of alpha 1 antitrypsin phenotypes in viral hepatitis B infected patients in Iran","volume":"33","author":"Hashemi","year":"2005","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2021.11.022_bib102","first-page":"602","article-title":"Heterozygous alpha 1-antitrypsin phenotypes in patients with end stage liver disease","volume":"92","author":"Eigenbrodt","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2021.11.022_bib103","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep.510260334","article-title":"Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study","volume":"26","author":"Serfaty","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.11.022_bib104","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hep.1840160124","article-title":"Association between heterozygous alpha 1-antitrypsin deficiency and genetic hemochromatosis","volume":"16","author":"Rabinovitz","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.11.022_bib105","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.1840180338","article-title":"Association between heterozygous alpha 1-antitrypsin deficiency and genetic hemochromatosis","volume":"18","author":"Kaserbacher","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.11.022_bib106","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/gut.36.6.922","article-title":"Increased PiZ gene frequency for alpha 1 antitrypsin in patients with genetic haemochromatosis","volume":"36","author":"Elzouki","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2021.11.022_bib107","first-page":"1161","article-title":"No association between genetic hemochromatosis and alpha1-antitrypsin deficiency","volume":"24","author":"Fargion","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2021.11.022_bib108","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.1093\/hmg\/ddv348","article-title":"Impaired hepcidin expression in alpha-1-antitrypsin deficiency associated with iron overload and progressive liver disease","volume":"24","author":"Schaefer","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jhep.2021.11.022_bib109","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1038\/s41436-019-0449-6","article-title":"SERPINA1 Z allele is associated with cystic fibrosis liver disease","volume":"21","author":"Bo\u00eblle","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.jhep.2021.11.022_bib110","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1073\/pnas.1117665109","article-title":"Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation","volume":"109","author":"Tawara","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2021.11.022_bib111","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1182\/blood-2014-04-570440","article-title":"\u03b1-1-Antitrypsin (AAT)-modified donor cells suppress GVHD but enhance the GVL effect: a role for mitochondrial bioenergetics","volume":"124","author":"Marcondes","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2021.11.022_bib112","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.ymthe.2019.05.007","article-title":"Alpha-1 antitrypsin-expressing mesenchymal stromal cells confer a long-term survival benefit in a mouse model of lethal GvHD","volume":"27","author":"Geiger","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.jhep.2021.11.022_bib113","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1161\/01.CIR.102.12.1420","article-title":"Functional protection by acute phase proteins alpha(1)-acid glycoprotein and alpha(1)-antitrypsin against ischemia\/reperfusion injury by preventing apoptosis and inflammation","volume":"102","author":"Daemen","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jhep.2021.11.022_bib114","doi-asserted-by":"crossref","first-page":"12153","DOI":"10.1073\/pnas.0505579102","article-title":"Alpha1-antitrypsin monotherapy prolongs islet\u00a0allograft survival in mice","volume":"102","author":"Lewis","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2021.11.022_bib115","doi-asserted-by":"crossref","first-page":"16236","DOI":"10.1073\/pnas.0807627105","article-title":"alpha1-Antitrypsin monotherapy induces immune tolerance during islet\u00a0allograft transplantation in mice","volume":"105","author":"Lewis","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2021.11.022_bib116","doi-asserted-by":"crossref","first-page":"16242","DOI":"10.1073\/pnas.0808031105","article-title":"Curative and \u03b2 cell regenerative effects of \u03b11-antitrypsin treatment in autoimmune diabetic NOD mice","volume":"105","author":"Koulmanda","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jhep.2021.11.022_bib117","doi-asserted-by":"crossref","first-page":"15443","DOI":"10.1073\/pnas.1018366109","article-title":"Alpha 1-antitrypsin reduces inflammation and enhances mouse pancreatic islet transplant survival","volume":"109","author":"Koulmanda","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jhep.2021.11.022_bib118","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/cmi.2014.17","article-title":"\u03b11-antitrypsin increases interleukin-1 receptor antagonist production during pancreatic islet graft transplantation","volume":"11","author":"Abecassis","year":"2014","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jhep.2021.11.022_bib119","doi-asserted-by":"crossref","first-page":"15007","DOI":"10.1073\/pnas.1309648110","article-title":"Anti-inflammatory and immunomodulatory properties of \u03b11-antitrypsin without inhibition of elastase","volume":"110","author":"Jonigk","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2021.11.022_bib120","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.healun.2013.10.031","article-title":"\u03b11-Antitrypsin inhibits ischemia reperfusion-induced lung injury by reducing inflammatory response and cell death","volume":"33","author":"Gao","year":"2014","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.jhep.2021.11.022_bib121","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.healun.2016.03.006","article-title":"Human \u03b11-antitrypsin improves early post-transplant lung function: pre-clinical studies in a pig lung transplant model","volume":"35","author":"Iskender","year":"2016","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.jhep.2021.11.022_bib122","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.healun.2017.09.019","article-title":"\u03b1(1)-Anti-trypsin improves function of porcine donor lungs during ex-vivo lung perfusion","volume":"37","author":"Lin","year":"2018","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.jhep.2021.11.022_bib123","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.healun.2018.03.015","article-title":"Preservation with \u03b1(1)-antitrypsin improves primary graft function of murine lung transplants","volume":"37","author":"G\u00f6tzfried","year":"2018","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.jhep.2021.11.022_bib124","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1182\/blood-2017-11-815746","article-title":"\u03b1(1)-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease","volume":"131","author":"Magenau","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2021.11.022_bib125","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2217\/imt-2018-0047","article-title":"Long-term safety of \u03b1-1 antitrypsin therapy in children and adolescents with Type 1 diabetes","volume":"10","author":"Brener","year":"2018","journal-title":"Immunotherapy"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827821022273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827821022273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:05:56Z","timestamp":1778508356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827821022273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":125,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0168827821022273"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2021.11.022","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alpha-1 antitrypsin deficiency: A re-surfacing adult liver disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2021.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}